One-third of colorectal cancer survival disparities a product of treatment gaps

Treatment disparities mediated about one-third of OS differences observed between white and Black patients with stage IV colorectal cancer, according to a retrospective cohort study presented at Gastrointestinal Cancers Symposium.This finding may be an underestimate because of the limited granularity of available treatment mediator variables, according to Douglas S. Swords, MD, MS, surgical oncology fellow at The University of Texas MD Anderson Cancer Center.“These results suggest that the oncology community should invest resources into developing interventions aimed at eliminatingRead More

Share on facebook
Share on twitter
Share on linkedin